Argus Upgrades Central Garden & Pet (NASDAQ:CENTA) to “Strong-Buy”
Central Garden & Pet (NASDAQ:CENTA – Get Free Report) was upgraded by stock analysts at Argus to a “strong-buy” rating in a report issued on...
Financial Review: AIM ImmunoTech (NYSE:AIM) & Monte Rosa Therapeutics (NASDAQ:GLUE)
Monte Rosa Therapeutics (NASDAQ:GLUE – Get Free Report) and AIM ImmunoTech (NYSE:AIM – Get Free Report) are both small-cap medical companies, but which is the...
Head to Head Comparison: Siemens Aktiengesellschaft (OTCMKTS:SIEGY) and GE Vernova (NYSE:GEV)
GE Vernova (NYSE:GEV – Get Free Report) and Siemens Aktiengesellschaft (OTCMKTS:SIEGY – Get Free Report) are both large-cap oils/energy companies, but which is the superior...
Financial Comparison: BridgeBio Pharma (NASDAQ:BBIO) & Crinetics Pharmaceuticals (NASDAQ:CRNX)
BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) and Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report) are both mid-cap medical companies, but which is the superior...
Xenia Hotels & Resorts, Inc. (NYSE:XHR) Receives $15.70 Consensus Target Price from Brokerages
Xenia Hotels & Resorts, Inc. (NYSE:XHR – Get Free Report) has been assigned a consensus rating of “Hold” from the six brokerages that are currently...
Critical Review: Gopher Protocol (OTCMKTS:GOPH) & 1847 (OTCMKTS:EFSH)
1847 (OTCMKTS:EFSH – Get Free Report) and Gopher Protocol (OTCMKTS:GOPH – Get Free Report) are both small-cap multi-sector conglomerates companies, but which is the better...